Bioparc Bordeaux Métropole
27 allée Charles Darwin
Poietis is a biotechnology company specializing in the design of regenerative medicine therapies based on 4D laser bio-printing. 4D bio-printing consists of programming tissue self-organization by designing organizations of tissue constituents (cells and extracellular matrix) that evolve in a controlled way until specific biological functions emerge.
6 articles with Poietis
Poietis, 4D Bioprinting company, announces the issuance by the European Patent Office of a third patent covering its bioprinting technology
Servier, an independent international pharmaceutical company, and Poietis, a leader in the production of living bioprinted tissues, have announced a scientific partnership to use Poietis’s 4D bioprinting technology for the development and production of liver tissues.
Poietis and Prometheus, division of skeletal tissue engineering of KU Leuven, enter into a Collaborative Research Agreement focused on 3D Bioprinting for skeletal ATMPs.
Poietis and Prometheus, entered into a 2-years Collaborative Research Agreement focused on high-precision 3D Bioprinting of tissue engineered Advanced Therapeutic Medicinal Products (ATMPs) for skeletal regeneration.
A recent survey by the Pew Research Center found that 57 percent of Americans surveyed thought it was appropriate to use genetically engineered animals to grow organs for human transplants.
6/21/2018Poietis along with Prometheus, a division of Skeletal Tissue Engineering at Leuven, Belgium, announced they had entered into a two-year Collaborative Research Agreement to develop high-precision 3D Bioprinting.
Poietis, a leading company in 4D bioprinting solutions, today announces the commercial launch of Poieskin, its first bioprinted skin model.